After 10 years of follow-up, cases with low MRPS23 expression levels had a cumulative risk of death from breast cancer of 26% (95% CI 23–29%), compared to 24% (95% CI 20–30%) among cases with high MRPS23 expression (Cut-off upper quartile; Fig. 6, Table 7). This evidence concerns the gene MRPS23 and breast carcinoma.